RE: 25p + Next Hopefully.24 Mar 2020 16:57
Thoth...What happened to the free fall this Monday now to 5p? Still not a holder but still very interested in pushing this share down, trading lows and highs and taking peoples money. I’m in long have been for nearly a year and it looks like others are holding until the financial report is out next week I’d say. See their very positive interim report below and they still had six months of earning after this with Greenbrook contributing also.
Interim results published by Totally this November gone included "Our overall cash management has been excellent, and we closed the period with £9.0m cash in the bank", 'consolidation with a very strong platform built for organic growth'. Organic growth. No placements required here IMHO. They have invested heavily so yes not allot of profit about then but there's been six months trading between then and now and they are very well placed to consolidate and grow now and years to come. They’ve done are doing what they set out to do. Saying that they still managed to pay out a dividend in February. They are also in the right place to assist the NHS in everyway, full utilisation. We’ll see.
Anyway see extract below and their statement link here. https://www.totallyplc.com/contact-us/#FSContact1
Financial Overview
Group turnover of £40,164,000 (Six months to 30 September 2017: £3,530,000)
Gross profit of £5,689,000 (Six months to 30 September 2017: £1,058,000)
Cash at Bank of £9,002,000 (31 March 2018: £10,224,000)
EBITDA profit before exceptional items £95,000 (Six months to 30 September 2017: EBITDA loss £804,000)
EBITDA profit including exceptional items £1,007,000 (Six months to 30 September 2017: EBITDA loss £784,000)
Operational Highlights
Totally is making progress with its Buy and Build Strategy and continues to integrate new innovative care models into its healthcare delivery pathways.
Across the Totally Group companies;
In excess of £10m new business and renewed contracts have been announced since the previous results announcement (10 July 2018); and
About Health has renewed all of its contracts as well as adding new business to its portfolio
Significant progress has been made in relation to service reviews undertaken by the Care Quality Commission (“CQC”) resulting in 70% of all sites inspected being rated Good.
The pipeline of business contract opportunities remains strong as the Company continues to focus on growth and maximising efficiency across the Group.
The Company remains focused on evaluating value accretive acquisition opportunities to consolidate the UK NHS outsourced healthcare services market, estimated to be worth in excess of £20 billion1 per year.
Post period end Vocare has been awarded a £3.3m contract extension for Staffordshire NHS 111 services until 31 March 2020.
The Chancellor announced an increase in NHS funding of £20.5 billion over a 5 year period in the 2018 budget.